ArriVent BioPharma, Inc. AVBP Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from ArriVent BioPharma, Inc.’s reported figures.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s invested capital?
- ArriVent BioPharma, Inc. (AVBP) reported invested capital of $262.3M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s invested capital changed year-over-year?
- ArriVent BioPharma, Inc.'s invested capital increased by 71.6% year-over-year, from $152.82M to $262.3M.
- What is the long-term trend for ArriVent BioPharma, Inc.'s invested capital?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s invested capital has grown at a -7.1% compound annual growth rate (CAGR), from -$303.27M to $261.7M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).